Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
The SURMOUNT-4 trial demonstrated that patients who discontinued tirzepatide after achieving weight loss regained significant weight compared to those who continued treatment, though not all weight loss was reversed during the study period
Lambert JMR, Gorzov P, Veprintsev DB, Sderqvist M, Segerbck D, Bergman J, et al
This process is governed by BCL2 family proteins, including the pro-apoptotic BCL2 associated X, apoptosis regulator (BAX) or BCL2 antagonist/killer 1 (BAK1, also known as BAK) as well as anti-apoptotic members, such as BCL2 apoptosis regulator (BCL2) and BCL2 like 1 (BCL2L1, also known as BCL-XL)
Research Overview Understanding BPC-157 BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide whose 15-amino-acid sequence was derived from a larger gastric protective protein first characterised by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s
Repletion Strategies While research continues on the role of glutathione deficiency in the pathophysiology of various diseases, it is clear that methods for repleting and maintaining glutathione will play an increasingly important role in the management of many conditions
